BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38318268)

  • 21. Reduced growth velocity across the third trimester is associated with placental insufficiency in fetuses born at a normal birthweight: a prospective cohort study.
    MacDonald TM; Hui L; Tong S; Robinson AJ; Dane KM; Middleton AL; Walker SP
    BMC Med; 2017 Aug; 15(1):164. PubMed ID: 28854913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predelivery placenta-associated biomarkers and computerized intrapartum fetal heart rate patterns.
    Bowe S; Mitlid-Mork B; Gran JM; Distante S; Redman CWG; Staff AC; Georgieva A; Sugulle M
    AJOG Glob Rep; 2023 Feb; 3(1):100149. PubMed ID: 36647548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).
    Chaiworapongsa T; Romero R; Erez O; Tarca AL; Conde-Agudelo A; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L; Korzeniewski SJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):682.e1-682.e13. PubMed ID: 29037482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of fetal trisomy 21 on umbilical artery Doppler indices.
    Kaur K; Acharya G; Chen H; Shannon CN; Lipscomb BE; Newman R; Zuckerwise LC
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8364-8371. PubMed ID: 34570672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal placental growth factor and soluble fms-like tyrosine kinase-1 reference ranges in post-term pregnancies: A prospective observational study.
    Mitlid-Mork B; Bowe S; Gran JM; Bolstad N; Berg JP; Redman CW; Staff AC; Sugulle M
    PLoS One; 2020; 15(10):e0240473. PubMed ID: 33079955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
    Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
    Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placental soluble fms-like tyrosine kinase expression in small for gestational age infants and risk for adverse outcomes.
    Spiel M; Salahuddin S; Pernicone E; Zsengeller Z; Wang A; Modest AM; Karumanchi SA; Hecht JL
    Placenta; 2017 Apr; 52():10-16. PubMed ID: 28454690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The additive role of angiogenic markers for women with confirmed preeclampsia.
    Suresh S; Patel E; Mueller A; Morgan J; Lewandowski WL; Verlohren S; von Dadelszen P; Magee LA; Rana S
    Am J Obstet Gynecol; 2023 May; 228(5):573.e1-573.e11. PubMed ID: 36356699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placental transcriptional and histologic subtypes of normotensive fetal growth restriction are comparable to preeclampsia.
    Gibbs I; Leavey K; Benton SJ; Grynspan D; Bainbridge SA; Cox BJ
    Am J Obstet Gynecol; 2019 Jan; 220(1):110.e1-110.e21. PubMed ID: 30312585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population.
    Kumar N; Das V; Agarwal A; Agrawal S
    AJOG Glob Rep; 2023 May; 3(2):100177. PubMed ID: 36911235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance and Outcomes of Fetal Growth Restriction Below the 5th Percentile Compared to the 5th to 10th Percentiles on Midgestation Growth Ultrasonography.
    Zhang-Rutledge K; Mack LM; Mastrobattista JM; Gandhi M
    J Ultrasound Med; 2018 Sep; 37(9):2243-2249. PubMed ID: 29476559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T2*-weighted placental magnetic resonance imaging: a biomarker of placental dysfunction in small-for-gestational-age pregnancies.
    Hansen DN; Sinding M; Petersen A; Christiansen OB; Uldbjerg N; Peters DA; Frøkjær JB; Sørensen A
    Am J Obstet Gynecol MFM; 2022 May; 4(3):100578. PubMed ID: 35114424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced growth velocity from the mid-trimester is associated with placental insufficiency in fetuses born at a normal birthweight.
    Kennedy LM; Tong S; Robinson AJ; Hiscock RJ; Hui L; Dane KM; Middleton AL; Walker SP; MacDonald TM
    BMC Med; 2020 Dec; 18(1):395. PubMed ID: 33357243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The magnitude rather than the rate of decline in fetal growth is a stronger risk factor for perinatal mortality in term infants.
    Larsen ML; Schreiber V; Krebs L; Hoei-Hansen CE; Kumar S
    Am J Obstet Gynecol MFM; 2023 Feb; 5(2):100780. PubMed ID: 36273814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diverse mechanisms underlying the fetal growth course in gastroschisis and omphalocele.
    Amylidi-Mohr S; Wyss M; Surbek D; Raio L; Mosimann B
    AJOG Glob Rep; 2023 Aug; 3(3):100238. PubMed ID: 37424955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum amyloid A1 and pregnancy zone protein in pregnancy complications and correlation with markers of placental dysfunction.
    Fosheim IK; Jacobsen DP; Sugulle M; Alnaes-Katjavivi P; Fjeldstad HES; Ueland T; Lekva T; Staff AC
    Am J Obstet Gynecol MFM; 2023 Jan; 5(1):100794. PubMed ID: 36334725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hemodynamics of late-onset intrauterine growth restriction by MRI.
    Zhu MY; Milligan N; Keating S; Windrim R; Keunen J; Thakur V; Ohman A; Portnoy S; Sled JG; Kelly E; Yoo SJ; Gross-Wortmann L; Jaeggi E; Macgowan CK; Kingdom JC; Seed M
    Am J Obstet Gynecol; 2016 Mar; 214(3):367.e1-367.e17. PubMed ID: 26475425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual risk assessment for prenatal counseling in early-onset growth-restricted and small-for-gestational-age fetuses.
    Mendoza M; Hurtado I; Bonacina E; Garcia-Manau P; Serrano B; Tur H; Rodo C; Maiz N; Carreras E
    Acta Obstet Gynecol Scand; 2021 Mar; 100(3):504-512. PubMed ID: 33098097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study.
    Gaccioli F; Sovio U; Cook E; Hund M; Charnock-Jones DS; Smith GCS
    Lancet Child Adolesc Health; 2018 Aug; 2(8):569-581. PubMed ID: 30119716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.